Financial statements Adapharm
Cash flow statement of Adapharm
Company age:
Age:
11 y. 2 m. 9 d.
Share capital:
Share capital:
200 000 PLN
Cash inflows of ADAPHARM
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Net cash from operating expenses | 479 350,04 | 526 211,65 | 1 027 447,06 | 1 756 658,73 | -1 143 975,95 | -902 277,13 |
| Net cash flow from investing activities | -1 331 228,15 | -167 025,17 | -81 451,05 | -23 600,00 | -79 583,71 | 196 399,06 |
| Net cash flow from financial activities | -608 839,08 | -779 059,36 | 1 610 818,00 | -163 261,09 | -3 239 734,85 | 1 648 313,51 |
| Total net cash flow | -1 460 717,19 | -419 872,88 | 2 556 814,01 | 1 569 797,64 | -4 463 294,51 | 942 435,44 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.